We are live on ! Find out more
ECTE

ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE

Delisted

ECTE was delisted on the 11th of July, 2016.

2 hedge funds and large institutions have $1K invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 12 (+1)

0% more capital invested

Capital invested by funds: $1K → $1K ($0)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Edge Wealth Management
New York
$1K

ECTE Hedge Fund Activity: Q4 2017 in Review

2 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q4 2017, worth a combined $1K — unchanged from a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ECTE positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q4 2017, up from 1 in Q3 2017.
  • Funds reported $1K of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q4 2017, unchanged quarter-over-quarter.
  • 1 fund opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q4 2017 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q4 2017.